Developing Comparability Strategies to Support Late Phase CMC Changes for an ADC Programme

12:00 pm - Monday 8th March 2027

  • Making process changes with line of sight of future commercial supply
  • Using a phase-appropriate and risk-informed • comparability strategy to support the introduction of postchange material into the clinic
  • Leveraging analytical and functional assessments to demonstrate comparability and maintain product quality following process changes

Speakers:

Director, Global Regulatory Affairs CMC
Eli Lilly & Co.